DaVita Inc. agrees to pay $34,487,390 to resolve False Claims Act allegations involving three distinct kickback schemes: paying a competitor to induce referrals to DaVita Rx pharmacy subsidiary in exchange for acquiring European dialysis clinics and extending dialysis product purchases; providing …
DaVitaDennis KogodDepartment of JusticeDaVita Rxhealthcaredialysismedicare-fraudkickbackswhistleblower+2 more
In 2016, a whistleblower who had worked for 12 years at the American Kidney Fund filed a lawsuit alleging that dialysis giants DaVita and Fresenius Medical Care—which together control over 80 percent of the $24.7 billion U.S. dialysis market—operated a years-long kickback scheme where they donated …
DaVitaFresenius Medical CareAmerican Kidney FundDepartment of JusticeFederal Trade Commissionhealthcaredialysissystematic-corruptionmonopolykickbacks+3 more
DaVita Healthcare Partners agrees to pay $450 million (ultimately $495 million) to resolve False Claims Act allegations that it knowingly created unnecessary waste in administering dialysis drugs Zemplar and Venofer, then fraudulently billed Medicare and Medicaid for the avoidable waste. …
DaVitaKent ThiryAlon J. VainerDaniel D. BarbirDepartment of Justicehealthcaredialysismedicare-fraudwhistleblowerpatient-harm+1 more
DaVita Healthcare Partners, the nation’s second-largest dialysis provider, agrees to pay $350 million to resolve False Claims Act allegations that it paid illegal kickbacks to physicians to induce patient referrals to its dialysis clinics from 2005-2014. The scheme involved DaVita offering …
DaVitaKent ThiryDepartment of JusticeHHS Office of Inspector Generalhealthcaredialysismedicare-fraudkickbacksregulatory-capture+2 more